<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">744707</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2021.744707</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Structural Characterization of the RNA-Binding Protein SERBP1 Reveals Intrinsic Disorder and Atypical RNA Binding Modes</article-title>
<alt-title alt-title-type="left-running-head">Baudin et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">SERBP1 Structure and RNA Binding</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Baudin</surname>
<given-names>Antoine</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1079246/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moreno-Romero</surname>
<given-names>Alma K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Xiaoping</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1475301/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Selig</surname>
<given-names>Emily E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1439299/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Penalva</surname>
<given-names>Luiz O. F.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/33914/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Libich</surname>
<given-names>David S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1376358/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Greehey Children&#x2019;s Cancer Research Institute, The University of Texas Health Science Center at San Antonio, <addr-line>San Antonio</addr-line>, <addr-line>TX</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Department of Biochemistry and Structural Biology, The University of Texas Health Science Center at San Antonio, <addr-line>San Antonio</addr-line>, <addr-line>TX</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Department of Cell Systems and Anatomy, The University of Texas Health Science Center at San Antonio, <addr-line>San Antonio</addr-line>, <addr-line>TX</addr-line>, <country>United&#x20;States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/819596/overview">Vincenzo Venditti</ext-link>, Iowa State University, United&#x20;States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1051749/overview">Lalit Deshmukh</ext-link>, University of California, San Diego, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1416744/overview">Jun Zhang</ext-link>, University of Alabama at Birmingham, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1253341/overview">Steven. T Whitten</ext-link>, Texas State University, United&#x20;States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: David S. Libich, <email>libich@uthscsa.edu</email>
</corresp>
<fn fn-type="other" id="fn1">
<label>
<sup>
<bold>&#x2020;</bold>
</sup>
</label>
<p>
<bold>ORCID:</bold>
</p>
<p>Antoine Baudin</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-1390-1196">orcid.org/0000-0002-1390-1196</ext-link>
</p>
<p>Emily. E. Selig</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-3012-6814">orcid.org/0000-0002-3012-6814</ext-link>
</p>
<p>David. S. Libich</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-6492-2803">orcid.org/0000-0001-6492-2803</ext-link>
</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Biophysics, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>744707</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>07</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>09</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Baudin, Moreno-Romero, Xu, Selig, Penalva and Libich.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Baudin, Moreno-Romero, Xu, Selig, Penalva and Libich</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>RNA binding proteins (RBPs) are essential for critical biological processes such as translation regulation and mRNA processing, and misfunctions of these proteins are associated with diseases such as cancer and neurodegeneration. SERBP1 (SERPINE1 mRNA Binding Protein 1) is an RBP that comprises two RG/RGG repeat regions yet lacks other recognizable RNA-binding motifs. It is involved in mRNA maturation, and translational regulation. It was initially identified as a hyaluronic acid binding protein, but recent studies have identified central roles for SERBP1 in brain function and development, especially neurogenesis and synaptogenesis. SERBP1 regulates One-carbon metabolism and epigenetic modification of histones, and increased SERBP1 expression in cancers such as leukemia, ovarian, prostate, liver and glioblastoma is correlated with poor patient outcomes. Despite these important regulatory roles for SERBP1, little is known about its structural and dynamic properties, nor about the molecular mechanisms governing its interaction with mRNA. Here, we define SERBP1 as an intrinsically disordered protein, containing highly conserved elements that were shown to be functionally important. The RNA binding activity of SERBP1 was explored using solution NMR and other biophysical techniques. The outcome of these experiments revealed that SERBP1 preferentially samples compact conformations including a central, stable &#x3b1;-helix and show that SERBP1 recognizes G-rich RNA sequences at the C-terminus involving the RGG box and neighboring residues. Despite the role in RNA recognition, the RGG boxes do not seem to stabilize the central helix and the central helix does not participate in RNA binding. Further, SERBP1 undergoes liquid-liquid phase separation, mediated by salt and RNA, and both RGG boxes are necessary for the efficient formation of condensed phases. Together, these results provide a foundation for understanding the molecular mechanisms of SERBP1 functions in physiological and pathological processes.</p>
</abstract>
<kwd-group>
<kwd>SERBP1</kwd>
<kwd>RNA binding protein</kwd>
<kwd>mRNA binding</kwd>
<kwd>intrinsically disordered protein</kwd>
<kwd>NMR</kwd>
</kwd-group>
<contract-num rid="cn001">634706</contract-num>
<contract-num rid="cn002">AQ-2001&#x2013;20190330</contract-num>
<contract-num rid="cn003">RP200595 RP170345</contract-num>
<contract-num rid="cn004">NIH P30 CA05417X4</contract-num>
<contract-sponsor id="cn001">Welch Foundation<named-content content-type="fundref-id">10.13039/100000928</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Max and Minnie Tomerlin Voelcker Fund<named-content content-type="fundref-id">10.13039/100006772</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Cancer Prevention and Research Institute of Texas<named-content content-type="fundref-id">10.13039/100004917</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">National Cancer Institute<named-content content-type="fundref-id">10.13039/100000054</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>SERBP1 (SERPINE1 mRNA binding protein 1) is a highly conserved RNA binding protein (RBP) containing two RG/RGG repeat regions yet lacks other readily recognizable, canonical or structured RNA binding motifs. RBPs containing RG/RGG repeats are essential for normal brain function and have been implicated in neurological and neuromuscular diseases as well as certain cancers (<xref ref-type="bibr" rid="B35">J&#xe4;rvelin et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B33">Hentze et&#x20;al., 2018</xref>). High SERBP1 expression in glioblastoma multiform (GBM) is linked to poor patient outcome and response to therapy while <italic>in&#x20;vitro</italic> and <italic>in vivo</italic> studies showed that expression levels of SERBP1 affect several related cancer phenotypes, stemness, neuronal differentiation and tumor growth (<xref ref-type="bibr" rid="B37">Koensgen et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B60">Serce et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B20">Costa et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B73">Wang et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B38">Kosti et&#x20;al., 2020</xref>). We recently established that SERBP1 functions as a novel oncogenic factor in GBM through regulation of One-carbon metabolism, methionine production, and histone methylation (<xref ref-type="bibr" rid="B38">Kosti et&#x20;al., 2020</xref>). Moreover, knockdown of SERBP1 affected the expression of genes linked to neurogenesis and synaptogenesis. A strong negative expression correlation was observed between genes in these categories and SERBP1 both in brain and patient-derived GBM samples, implicating SERBP1 in brain function and development (<xref ref-type="bibr" rid="B38">Kosti et&#x20;al., 2020</xref>). Two proximity-dependent biotinylating screening studies identified SERBP1 as an interaction partner of RBPs known to regulate synaptic plasticity such as FMR1, FXR1, FXR2, CAPRIN1, and SYNCRIP (<xref ref-type="bibr" rid="B77">Youn et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B26">Go et&#x20;al., 2021</xref>). Additionally, SERBP1 has a role in the SUMOylation of certain proteins (<xref ref-type="bibr" rid="B43">Lemos and Kobarg, 2006</xref>), and is itself SUMOylated (<xref ref-type="bibr" rid="B32">Hendriks et&#x20;al., 2014</xref>) on a lysine-rich sequence between the two RGG boxes. SUMOylation of SERBP1 has been suggested as a factor in the development of GBM, as aberrations in SUMOylation pathways can lead to the development of cancer (<xref ref-type="bibr" rid="B25">Fox et&#x20;al., 2019</xref>).</p>
<p>SERBP1 structure and its RNA recognition and binding activity are poorly characterized. SERBP1 was reported to bind preferentially to GC-rich motifs (<xref ref-type="bibr" rid="B38">Kosti et&#x20;al., 2020</xref>), subsequent studies revealed that these motifs could include G-quadruplexes (<xref ref-type="bibr" rid="B66">Su et&#x20;al., 2021</xref>). SERBP1 was identified in the structures of non-translating 80&#xa0;S ribosomes, blocking the mRNA entrance channel suggesting that it serves to regulate mRNA translation (<xref ref-type="bibr" rid="B1">Ahn et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B10">Brown et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B50">Muto et&#x20;al., 2018</xref>). Like SERBP1, the SARS-CoV-2&#x20;non-structural protein 1 (Nsp1) mediates translation inhibition of mRNA by binding and blocking the ribosomal mRNA channel through interactions with its disordered C-terminal domain (<xref ref-type="bibr" rid="B58">Schubert et&#x20;al., 2020</xref>). Translational regulation does not account for the RNA binding activity of SERBP1 and thus it likely participates in additional regulatory processes. For instance, vig and vig2, SERBP1 Drosophila homologues, have been identified in RNAi complexes and heterochromatin, (<xref ref-type="bibr" rid="B27">Gracheva et&#x20;al., 2009</xref>), and as regulators of histone genes (<xref ref-type="bibr" rid="B70">Tsui et&#x20;al., 2018</xref>). As noted above, SERBP1 also interacts with arginine-methylated and stress granule-associated proteins (<xref ref-type="bibr" rid="B77">Youn et&#x20;al., 2018</xref>), and selective methylation of either RGG repeat region modulates its subcellular distribution between the nucleus and cytoplasm (<xref ref-type="bibr" rid="B41">Lee et&#x20;al., 2012a</xref>). To better understand the structural determinants guiding SERBP1 roles in these diverse physiological and pathological processes, a structural and biophysical analysis was undertaken to characterize its structural and functional properties. A combination of solution NMR spectroscopy and biophysical assays were used to define the structural and dynamic properties of SERBP1. The data reveal that SERBP1 is primarily an intrinsically disordered protein (IDP) yet it adopts compact, and partially structured conformations. Moreover, the SERBP1 binding site of a GC-rich RNA oligonucleotide was identified, and it was determined that RNA binding negatively affects the liquid-liquid phase separation (LLPS) propensity of SERBP1. Together, these results are a step toward understanding the multifunctional nature of SERBP1 and determining the structural underpinnings of its diverse physiological roles in healthy cells as well as its aberrant function in GBM and other tumor&#x20;types.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Phylogenetics</title>
<p>COBALT was used to perform multiple sequence alignment to identify conserved regions among SERBP1 homologues from eleven different species (nine different phyla) (<xref ref-type="bibr" rid="B52">Papadopoulos and Agarwala, 2007</xref>). Amino-acid identity was prioritized, and an amino-acid was defined as conserved if it was present in at least seven species. Protein sequences were obtained from the NCBI (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>) with the following accession numbers: <italic>H. sapiens</italic> (NP_001018077.1), <italic>Saccoglossus kowalevskii</italic> (XP_002740974.1), <italic>Acanthaster planci</italic> (XP_022107686.1), <italic>Drosophila melanogaster</italic> (NP_523572.1), <italic>Stegodyphus mimosarum</italic> (KFM69747.1), <italic>Centruroides sculpturatus</italic> (XP_023216060.1), <italic>Octopus sinensis</italic> (XP_029640355.1), <italic>Teladorsagia circumcincta</italic> (PIO76243.1), <italic>Echinococcus granulosus</italic> (XP_024349465.1), <italic>Nematostella vectensis</italic> (XP_001637231.1), <italic>A. queenslandica</italic> (XP_011406826.2).</p>
</sec>
<sec id="s2-2">
<title>Protein Expression and Purification</title>
<p>The SERBP1 189&#x2013;400 construct (Addgene accession number 172315) was expressed in <italic>E.coli</italic> as previously described (<xref ref-type="bibr" rid="B4">Baudin et&#x20;al., 2021</xref>). The genes for full-length SERBP1 and a SERBP1 149-400 construct were amplified by PCR (primer are shown in <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>), digested by <italic>Kas</italic>I and <italic>Bam</italic>HI restriction enzymes and cloned into a custom pAG8Ha-His vector that introduced an 8x histidine tag followed by a TEV cleavage site N-terminal to the coding sequence. Plasmids were transformed by heat shock into <italic>E.&#x20;coli</italic> BL21 Star&#x2122; (DE3) (Invitrogen, MA) and a colony from the resultant agar plate was used to inoculate a 5&#xa0;ml LB starter culture that was grown at 37<sup>&#xb0;</sup>C for 6&#x2013;8&#xa0;h. The LB starter culture was used to inoculate a 100&#xa0;ml M9 preculture that was grown overnight at 37<sup>&#x00B0;</sup>C with shaking. The overnight preculture was then used to inoculate an expression culture of 900&#xa0;ml M9 minimal media. Both the 100&#xa0;ml starter and 900&#xa0;ml expression cultures were supplemented with <sup>15</sup>NH<sub>4</sub>Cl (<sup>13</sup>C-glucose) for isotopic enrichment. For non-isotopically enriched protein, the overnight culture was 10&#xa0;ml LB and 4&#xa0;ml was used to inoculate a 1&#xa0;L LB expression culture. All cultures were supplemented with 100&#xa0;&#x3bc;g/&#xa0;ml of ampicillin. Expression cultures were grown at 37&#x00B0;C in baffled Fernbach flasks with shaking, and protein expression was induced at OD<sub>600</sub> &#x223c;0.6&#x2013;0.8 with 1&#xa0;mM IPTG and continued for 3 or 6&#xa0;h, for LB or M9 cultures, respectively. The cells were harvested by centrifugation at 4000&#xa0;g for 20&#xa0;min and the resulting pellets were stored at &#x2212;80&#xb0;C.</p>
<p>SERBP1 constructs were purified as previously described for SERBP1 189&#x2013;400 (<xref ref-type="bibr" rid="B4">Baudin et&#x20;al., 2021</xref>). Briefly, frozen <italic>E.&#x20;coli</italic> pellets were thawed and resuspended in 8&#xa0;M urea, 50&#xa0;mM Tris pH 8.0, 150&#xa0;mM NaCl, 20&#xa0;mM imidazole, lysed by sonication (6 cycles of 10&#xa0;s on, 30&#xa0;s off), and the lysate was cleared by centrifugation for 30&#xa0;min at 45000&#xa0;g at 4&#xb0;C. The supernatant was applied to a 5&#xa0;ml HisTrap HP column (Cytiva, MA, United&#x20;States), equilibrated with the lysis buffer, washed with 25 column volumes of the same buffer, and eluted with 8&#xa0;M urea, 50&#xa0;mM Tris pH 8.0, 150&#xa0;mM NaCl, 500&#xa0;mM imidazole. Eluted protein was concentrated with a 3&#xa0;kDa (149&#x2013;400, 189&#x2013;400) or 10&#xa0;kDa (full-length) cutoff Amicon centrifugal concentrator (Merck, NJ, United&#x20;States) to &#x223c;4&#xa0;ml and diluted into 40&#xa0;ml of 100&#xa0;mM sodium phosphate buffer, pH 7, 1&#xa0;mM PMSF, 1&#xa0;mM EDTA buffer. Precipitated protein was removed by centrifugation at 3,000&#xa0;g for 15&#xa0;min, and the protein was then dialyzed against 100&#xa0;mM sodium phosphate buffer pH 7 (3 x 2&#xa0;L), on the third change 500&#xa0;&#xb5;L of 1.6&#xa0;mg/&#xa0;ml Tobacco Etch Virus (TEV) protease was added and the mixture was incubated at room temperature overnight. The 8x His tag was not removed from full-length SERBP1. Post-dialysis, the sample was centrifugated at 3,000&#xa0;g for 15&#xa0;min to remove any precipitate and concentrated to approximately 4&#xa0;ml with an Amicon centrifugal concentrator. A final cation exchange chromatography polishing step was used for SERBP1 149&#x2013;400 and 189&#x2013;400. The 4&#xa0;ml sample was diluted into 60&#xa0;ml with 50&#xa0;mM sodium acetate buffer pH 4.5, 0.5&#xa0;mM PMSF, 0.5&#xa0;mM EDTA, loaded on a 5&#xa0;ml SP Sepharose fast-flow column (Cytiva, MA, United&#x20;States), washed with 20 column volumes of the same buffer and eluted with a 0.05&#x2013;1&#xa0;M NaCl gradient. Fractions containing SERBP 149&#x2013;400 were concentrated, and buffer exchanged into NMR buffer (20&#xa0;mM sodium phosphate buffer pH 6.9, 60&#xa0;mM NaCl, 1&#xa0;mM PMSF, 0.2&#xa0;mM EDTA, 10 %&#x20;D<sub>2</sub>O).</p>
</sec>
<sec id="s2-3">
<title>NMR Spectroscopy</title>
<p>All experiments were recorded on a Bruker Avance NEO spectrometer operating at a proton Larmor frequency of 700.13 MHz, at a temperature of 5&#x00B0;C using a 5&#xa0;mm TCI <italic>z</italic>-axis gradient cryogenic probe. Data were processed with the NMRPipe software suite (<xref ref-type="bibr" rid="B22">Delaglio et&#x20;al., 1995</xref>) and analyzed with CCPNMR Analysis 2.5 software (<xref ref-type="bibr" rid="B63">Skinner et&#x20;al., 2016</xref>). SERBP1 149&#x2013;400&#x20;<sup>1</sup>H, <sup>13</sup>C<sub>&#x3b1;</sub>, <sup>13</sup>C<sub>&#x3b2;</sub>, <sup>13</sup>C&#x2019; and <sup>15</sup>N backbone resonances were assigned through the analysis of a set of 2D and 3D experiments, namely <sup>1</sup>H,<sup>15</sup>N-HSQC, HNCACB, CBCA(CO)NH, HNCO, HN(CA)CO and HCC(CO)NH, recorded on a <sup>13</sup>C,<sup>15</sup>N-labeled sample at a concentration of 300&#xa0;&#x3bc;M, in NMR buffer. The <sup>1</sup>H,<sup>15</sup>N-HSQC was recorded with 128&#x2a;x 1024&#x2a; complex points in the indirect (<sup>15</sup>N) and direct (<sup>1</sup>H) dimensions, corresponding to acquisition times of 75.2 and 112.6&#xa0;ms, respectively. Acquisition parameters for the HNCO and HN(CA)CO consisted of 32<sup>&#x2217;</sup> x 64<sup>&#x2217;</sup> x 1024<sup>&#x2217;</sup> complex points in the indirect (F1, <sup>13</sup>C), (F2, <sup>15</sup>N) and direct (F3&#x20;<sup>1</sup>H) dimensions, corresponding to acquisition times of 16.5, 37.6, 112.6&#xa0;ms, respectively; acquisition parameters for the HNCACB, CBCA(CO)NH and HCC(CO)NH consisted of 128<sup>&#x2217;</sup> x 64<sup>&#x2217;</sup> x 1024<sup>&#x2217;</sup> complex points in the indirect (F1, <sup>13</sup>C), (F2, <sup>15</sup>N) and direct (F3&#x20;<sup>1</sup>H) dimensions, corresponding to acquisition times of 11, 37.6, 112.6&#xa0;ms, respectively. All 3D experiments were recorded in non-uniform sampling (NUS) mode (<xref ref-type="bibr" rid="B23">Delaglio et&#x20;al., 2017</xref>) with a sampling density of 20%, and the spectra were reconstructed using the SMILE algorithm implemented in NMRPipe (<xref ref-type="bibr" rid="B76">Ying et&#x20;al., 2017</xref>).</p>
<p>
<sup>15</sup>N <italic>R</italic>
<sub>1</sub> and <italic>R</italic>
<sub>2</sub> relaxation rates were calculated from <italic>T</italic>
<sub>1</sub> and <italic>T</italic>
<sub>1<italic>&#x3c1;</italic>
</sub> experiments, recorded on 50 and 100&#xa0;&#xb5;M samples for SERBP1 189&#x2013;400 and SERBP1 149&#x2013;400, respectively, in NMR buffer using 64&#x2a; x 1024&#x2a; complex data points in the indirect (<sup>15</sup>N) and direct (<sup>1</sup>H) dimensions corresponding to acquisition times of 37.6 and 112.6&#xa0;ms, respectively. The <sup>15</sup>N <italic>T</italic>
<sub>1</sub> experiment consisted of eight interleaved spectra with the following relaxation delays: 40, 80, 200, 280, 300, 400, 600, and 800&#xa0;ms. The <italic>T</italic>
<sub>1<italic>&#x3c1;</italic>
</sub> experiment was recorded using a <italic>B</italic>
<sub>1</sub> field of 1400&#xa0;Hz and eight interleaved spectra with the following relaxation delays: 1, 21, 31, 41, 61, 81, 121 and 161&#xa0;ms. <sup>15</sup>N <italic>R</italic>
<sub>2</sub> rates were calculated using the following equation (<xref ref-type="bibr" rid="B49">Massi et&#x20;al., 2004</xref>):<disp-formula id="e1">
<mml:math id="m1">
<mml:mrow>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mi>&#x3c1;</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msup>
<mml:mrow>
<mml:mtext>cos</mml:mtext>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mi>&#x3b8;</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msup>
<mml:mrow>
<mml:mtext>sin</mml:mtext>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mi>&#x3b8;</mml:mi>
<mml:mo>&#xa0;</mml:mo>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>with &#x3b8; &#x3d; arctan(<italic>&#x3c9;</italic>
<sub>1</sub>/&#x3a9;), where <italic>&#x3c9;</italic>
<sub>1</sub> is the <italic>B</italic>
<sub>1</sub> field strength (here 1400&#xa0;Hz) and &#x3a9; is the offset from the spinlock carrier frequency. <sup>1</sup>H-<sup>15</sup>N heteronuclear NOE experiments were recorded on the same samples and consisted of two interleaved experiments, with and without proton saturation, using a recycle delay of 4&#xa0;s. Spectra were acquired with 64<sup>&#x2217;</sup> x 1024<sup>&#x2217;</sup> complex data points in the indirect (<sup>15</sup>N) and direct (<sup>1</sup>H) dimensions corresponding to acquisition times of 37.6 and 112.6&#xa0;ms, respectively.</p>
<p>For RNA binding experiments, SERBP1 189&#x2013;400 or 149&#x2013;400 samples were diluted to 50&#xa0;&#xb5;M in 500&#xa0;&#xb5;L in NMR buffer and added to a 5&#xa0;mm NMR tube. The RNA sequence 5&#x2032;-GCGCGGG-3&#x2032;, representing a G-quartet, was synthesized (IDT, IA), desalted, dried, and resuspended in RNAase-free water (Qiagen, MD) to a concentration of 3.125&#xa0;mM. The RNA stock was titrated into the SERBP1 sample to final RNA:SERBP1 ratios of 2:5, 4:5, 6:5, and 8:5. This required the addition of a maximum of 12&#xa0;&#xb5;L of the RNA stock, thus the effect of dilution is negligible. <sup>1</sup>H,<sup>15</sup>N-HSQC spectra were recorded at 4&#x00B0;C for each titration point with 64<sup>&#x2217;</sup> x 1024<sup>&#x2217;</sup> complex data points in the indirect (<sup>15</sup>N) and direct (<sup>1</sup>H) dimensions corresponding to acquisition times of 37.6 and 112.6&#xa0;ms, respectively. Spectra were apodized with a sine bell function and zero filled to twice the number of acquired points for data analysis. Chemical shift perturbations (CSP) were calculated by weighting the <sup>1</sup>H and <sup>15</sup>N chemical shifts with respect to their gyromagnetic ratio using the following equation (<xref ref-type="bibr" rid="B75">Williamson, 2013</xref>):<disp-formula id="e2">
<mml:math id="m2">
<mml:mrow>
<mml:mtext>&#x394;&#x3b4;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:msqrt>
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mtext>&#x3b4;</mml:mtext>
<mml:msup>
<mml:mo>&#x2009;</mml:mo>
<mml:mn>1</mml:mn>
</mml:msup>
<mml:mtext>H</mml:mtext>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.1</mml:mn>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mtext>&#x3b4;</mml:mtext>
<mml:mrow>
<mml:mn>15</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mtext>N</mml:mtext>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>CSPs were considered significant when they were higher than the standard deviation of &#x394;&#x3b4;<sub>max</sub> for all residues (<xref ref-type="bibr" rid="B75">Williamson, 2013</xref>).</p>
</sec>
<sec id="s2-4">
<title>CD Spectroscopy</title>
<p>Circular dichroic spectra were recorded on 10&#xa0;&#xb5;M samples of SERBP1 149&#x2013;400 or 189&#x2013;400 dissolved in 20&#xa0;mM Na<sub>2</sub>HPO<sub>4</sub> pH 6.9, 60&#xa0;mM NaCl in a 2&#xa0;mm pathlength circular cuvette using a Jasco 810 spectropolarimeter (Jasco, OK) at a scan speed of 50&#xa0;nm/&#xa0;min with 0.5&#xa0;nm. Temperature was controlled with a recirculating external water bath and was allowed to equilibrate for 20&#xa0;min before recording data after each ramp. Each temperature point (20&#x2013;80&#x00B0;C in 10&#x00B0;C steps) was recorded in triplicate, averaged and converted to mean residual ellipticity using previously described relationships (<xref ref-type="bibr" rid="B15">Chemes et&#x20;al., 2012</xref>).</p>
</sec>
<sec id="s2-5">
<title>Size Exclusion Chromatography</title>
<p>Size exclusion chromatography (SEC) experiments were performed using a BioRad NGC fast-performance liquid chromatography system (BioRad, CA, United&#x20;States) equipped with a Superdex 200&#x20;10 x 300&#xa0;mm analytical size exclusion column (Cytiva, MA, United&#x20;States), equilibrated with NMR buffer (20&#xa0;mM Na<sub>2</sub>HPO<sub>4</sub> pH 6.9, 60&#xa0;mM NaCl, 1&#xa0;mM PMSF, 0.2&#xa0;mM EDTA) in the presence or absence of 2&#xa0;M guanidinium hydrochloride (GdnHCl). 200&#xa0;&#xb5;L of a 15&#xa0;&#xb5;M sample of SERBP1 189&#x2013;400 or 149&#x2013;400 was applied to the column. The flow rate was 0.5&#xa0;ml/&#xa0;min, and elution was monitored at three wavelengths: 215, 280, and 340&#xa0;nm.</p>
</sec>
<sec id="s2-6">
<title>Analytical Ultracentrifugation</title>
<p>SERBP1 189&#x2013;400 and 149&#x2013;400 stock samples were diluted to a concentration of 25&#xa0;&#xb5;M into 20&#xa0;mM Na<sub>2</sub>HPO<sub>4</sub> pH 7.0, 60&#xa0;mM NaCl buffer, in presence or absence of 2&#xa0;M GdnHCl. 360&#xa0;&#xb5;L samples were loaded into one sector of a 12&#xa0;mm double-sector epon-filled centerpiece, and 400&#xa0;&#xb5;L of a reference solution of the sample buffer was loaded into the other sector. Radial absorbance scans were collected at 4&#xa0;min intervals at 280&#xa0;nm, using an XL-1 analytical centrifuge (Beckman Coulter, CA, United&#x20;States) equipped with a Ti60 rotor at 40000&#xa0;rpm, 20&#xb0;C. Total experiment time was &#x223c;10&#xa0;h. Data was fit using a continuous c(s) distribution model using the SEDFIT software (<xref ref-type="bibr" rid="B59">Schuck, 2000</xref>), using adjusted buffer density (1.04861) and buffer relative viscosity (1.09833) values to account for GdnHCl.</p>
</sec>
<sec id="s2-7">
<title>Dynamic Light Scattering</title>
<p>A SERBP1 189&#x2013;400 stock sample was diluted to a concentration of 125&#xa0;&#xb5;M in 60&#xa0;&#xb5;L of 20&#xa0;mM Na<sub>2</sub>HPO<sub>4</sub> pH 7.0, 60&#xa0;mM NaCl buffer, in presence or absence of 2&#xa0;M GdnHCl, and transferred to a low-volume quartz cuvette. Measurements were conducted on a DynaPro NanoStar dynamic light scattering (DLS) instrument (Wyatt, CA, United&#x20;States) at 20&#xb0;C. For each sample 150&#x20;10&#xa0;s acquisitions were collected and averaged. Data were analyzed using the algorithms available in the instrument control software and output as size distributions. Experimentally measured <italic>R</italic>
<sub>h</sub> values were compared with calculated <italic>R</italic>
<sub>h</sub> values using the following equation proposed by Marsh and Forman-Kay to account for intrinsic disorder (<xref ref-type="bibr" rid="B47">Marsh and Forman-Kay, 2010</xref>):<disp-formula id="e3">
<mml:math id="m3">
<mml:mrow>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mtext>h</mml:mtext>
<mml:mrow>
<mml:mtext>IDP</mml:mtext>
</mml:mrow>
</mml:msubsup>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>2.49</mml:mn>
<mml:msup>
<mml:mi>N</mml:mi>
<mml:mrow>
<mml:mn>0.509</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
<label>(3)</label>
</disp-formula>where N is the number of residues in the protein polymer&#x20;chain.</p>
</sec>
<sec id="s2-8">
<title>Phase Separation</title>
<p>SERBP1 149&#x2013;400 was labeled with the DyLight&#x2122; 650 fluorophore (Thermo Fisher Scientific, MO, United&#x20;States) at the N-terminus using <italic>S. aureus</italic> sortase A following established protocols (<xref ref-type="bibr" rid="B68">Theile et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B3">Antos et&#x20;al., 2017</xref>). The sortase-recognition peptide KLPETGG was synthesized, HPLC purified, lyophilized (Genscript, NJ) and reacted with the fluorophore following the manufacturer&#x2019;s instructions. The fluorescently labeled peptide and SERBP1 were mixed at a 1:1&#xa0;molar ratio. Recombinant sortase A was added to a final concentration of 2.5&#xa0;&#xb5;M and the reaction was allowed to proceed overnight at room temperature. Labeled SERBP1 was separated from unconjugated peptide and free fluorophore by passing over a Superdex 75 HiLoad 16/60 size exclusion column (Cytiva, MA, United&#x20;States).</p>
<p>Torula yeast RNA (MilliporeSigma, MA, United&#x20;States) was dissolved at 10&#xa0;mg/ml in 20&#xa0;mM Tris pH 7.4, 150&#xa0;mM NaCl, centrifuged at 13000&#xa0;g for 10&#xa0;min, desalted using a PD-10 desalting column (Cytiva, MA, United&#x20;States), and diluted to a final stock concentration of 3.6&#xa0;mg/ml determined by A<sub>260</sub>. Unlabeled SERBP1 149&#x2013;400 was mixed with DyLight 650-labeled SERBP1 149&#x2013;400&#xa0;at a molar ratio of 0.03% and dissolved to 6 or 12&#xa0;&#xb5;M in 154&#xa0;mM NaCl, 64&#xa0;mM Tris pH 7.5, 12.8 % (v/v) glycerol, 1.28&#xa0;mM DTT, 12.8 % (w/v) PEG3000. Stock RNA was added to a final concentration of 0.4, 0.2, or 0.05&#xa0;mg/&#xa0;ml. Samples of SERBP1 189&#x2013;400 were prepared identically except without fluorescent labeling. Control samples consisting of buffer only or buffer plus RNA only remained clear. SERBP1 samples used in the salt series were prepared similarly except the buffer the protein was dissolved in contained only 20&#xa0;mM Tris pH 7.5 and 0, 0.05, 0.15, 0.3, or 1&#xa0;M&#x20;NaCl.</p>
<p>Phase separation was assayed by transferring 4.5&#xa0;&#xb5;L samples to chambered glass coverslips (Grace Biolabs, OR). Chambers were sealed with a second coverslip to reduce evaporation and incubated for 10&#xa0;min at ambient temperature before imaging with an Olympus FV3000 inverted confocal microscope (Olympus, PA, United&#x20;States) operating at 1% laser power on the 640&#xa0;nm channel. Images were acquired simultaneously in differential interference contrast (DIC) and fluorescent modes. Fluorescence recovery after photobleaching (FRAP) measurements were conducted on 12&#xa0;&#xb5;M SERBP1 149&#x2013;400 samples with low (0.05&#xa0;mg/&#xa0;ml) or no RNA, and generally recovered to &#x223c;80% of the initial fluorescent intensity. Image contrast was adjusted globally, and droplet area was measured using the appropriate subroutines in Fiji (ImageJ) (<xref ref-type="bibr" rid="B57">Schindelin et&#x20;al., 2012</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>SERBP1 is an Atypical RBP Lacking Canonical RNA Binding Motifs</title>
<p>The largest and predominant SERBP1 isoform contains 408&#xa0;amino-acids encompassing distinct domains including two hyaluronic acid binding protein (HABP) homology domains, IHABP4 (intracellular HABP4, spanning residues 5&#x2013;152) and HABP4 (residues 189&#x2013;314) as indicated by UniProtKB entry Q8NC51 (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). Two distinct RG/RGG repeats or boxes comprising residues 165&#x2013;184 and 366&#x2013;386 are important for RNA-binding and LLPS (<xref ref-type="bibr" rid="B16">Chong et&#x20;al., 2018</xref>). Aside from the RGG boxes, SERBP1 does not contain any other identifiable RNA-binding motif such as an RNA-recognition motif (RRM), zinc-finger, or K-homology (KH) domain (<xref ref-type="bibr" rid="B46">Maris et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B72">Valverde et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B19">Cook et&#x20;al., 2015</xref>). We used the PSIPRED (<xref ref-type="bibr" rid="B11">Buchan and Jones, 2019</xref>) and DISOPRED3 (<xref ref-type="bibr" rid="B74">Ward et&#x20;al., 2004</xref>) webservers to predict regions of secondary structure and intrinsic disorder respectively in SERBP1 (<xref ref-type="fig" rid="F1">Figures 1B,C</xref>). The results of the PSIPRED algorithm, shown as a cartoon representation (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>), predicts two regions of secondary structure roughly spanning residues 5&#x2013;80 and 270&#x2013;360. These results align well with the DISOPRED3 algorithm predictions which indicate SERBP1 is predominantly disordered, except for the first &#x223c;40&#xa0;N-terminal residues and residues 285&#x2013;300 (<xref ref-type="fig" rid="F1">Figure&#x20;1C</xref>). Several other segments of SERBP1 approach the cutoff threshold for order (e.g., 230&#x2013;240, 320&#x2013;330, 350&#x2013;365, 395&#x2013;408) and align well with the PSIPRED secondary structure predictions indicating the potential for transiently-formed structure.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Structural predictions and sequence alignments of human SERBP1. <bold>(A)</bold> Schematic representation of the three SERBP1 constructs. Green boxes represent the RG/RGG repeats, purple and cyan boxes represent the IHABP4 and HABP4 homology domains, respectively. Sequence numbering is from human SERBP1 and indicate the starting and ending amino acids of each domain. <bold>(B)</bold> Representation of SERBP1 secondary structure predicted by PSIPRED. Orange spirals and yellow arrows represent &#x3b1;-helices and &#x3b2;-strands, respectively. <bold>(C)</bold> Disorder plot of SERBP1 predicted by the DISOPRED3 algorithm. Residues with predicted values greater than the 0.5 threshold are predicted as disordered, while residues with values less than the threshold are predicted as structured. <bold>(D)</bold> Sequence alignment of the human SERBP1 sequence with invertebrate homologues. Red denotes conserved residues, blue indicates semi-conserved residues, grey boxes indicate non-conserved residues and red lines indicate gaps. Dashed boxes labeled with roman numerals align the regions of high sequence conservation with predicted regions of order <bold>(panel C)</bold>.</p>
</caption>
<graphic xlink:href="fmolb-08-744707-g001.tif"/>
</fig>
<p>SERBP1 is highly conserved among vertebrates, thus to gain insight into the functional relevance of the different domains of SERBP1, we aligned human SERBP1 to several homologous proteins from invertebrates (<xref ref-type="fig" rid="F1">Figure&#x20;1D</xref>). The alignments are shown with gaps, and dashed boxes denote regions with conserved (red) or semi-conserved (blue) sequence homology. Full alignments are presented in <xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>. Notably, the highly homologous regions align well with the predicted secondary structure (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>) and ordered regions (<xref ref-type="fig" rid="F1">Figure&#x20;1C</xref>), in particular residues 285&#x2013;300, which are predicted to be helical, are highly conserved (region &#x201c;III&#x201d; in <xref ref-type="fig" rid="F1">Figures 1C,D</xref>), indicating a potentially crucial role for SERBP1 function. Moreover, it appears that although the two RGG boxes show high conservation among vertebrates, these regions are highly heterogeneous among non-vertebrates (<xref ref-type="fig" rid="F1">Figure&#x20;1D</xref>; <xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). To expand on the role of the RGG boxes for SERBP1 function, we designed two truncated constructs: 149&#x2013;400 or 189&#x2013;400 which contain either both (149&#x2013;400) or only the C-terminal (189&#x2013;400) RGG box(es) (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). In both constructs, we also removed eight C-terminal residues (401&#x2013;408) that are hydrophobic and contributed to instability and were consistently degraded from SERBP1. To confirm that the truncated proteins faithfully reproduce the structural features of the full-length protein, <sup>1</sup>H,<sup>15</sup>N-HSQC spectra were recorded. Overlays of the spectra from full-length SERBP1 with spectra from each of the truncation proteins are almost identical indicating that the truncations did not lead to major structural changes (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>). The N-terminal region, that was predicted as structured, was not detected as such in the full-length spectrum, and thus we decided to focus our study on the truncated proteins.</p>
</sec>
<sec id="s3-2">
<title>Structural Characterization of SERBP1 Indicates the Presence of a Stable &#x3b1;-Helix</title>
<p>We previously reported the backbone resonance assignments for SERBP1 189&#x2013;400 (BMRB accession number 50953) and here we report the backbone resonance assignments for SERBP1 149&#x2013;400 (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). Over 77% of the backbone resonances from the 252 residue SERBP1 149&#x2013;400 were assigned, excluding the 11 proline residues. Of the 56 residues not assigned, 32 are arginines or glycines that belong to the two RG/RGG repeats and thus, because of the inherent sequence degeneracy in these regions, could not be unambiguously assigned. The remining 24 residues were either ambiguous or were severely overlapped in the spectrum. Overall, assignments of SERBP1 149&#x2013;400&#xa0;C&#x3b1;, C&#x3b2;, and C&#x2032; chemical shifts were 81, 84.6, and 77.8% complete respectively. Analysis of the C&#x3b1;, C&#x3b2;, C&#x2019;, H<sub>N</sub>, N, and H&#x3b1; chemical shifts using the Secondary Structure Propensity (SSP) algorithm (<xref ref-type="bibr" rid="B48">Marsh et&#x20;al., 2006</xref>) indicate that the majority of SERBP1 189&#x2013;400 is disordered, except for residues 289&#x2013;299, which have significant &#x3b1;-helical character (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). A similar analysis for the 149&#x2013;400 construct revealed &#x3b1;-helical propensity for the same residues (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>), indicating that the first RGG domain does not influence the formation or stability of the helix. Similar results were obtained with the &#x3b4;2D (<xref ref-type="bibr" rid="B13">Camilloni et&#x20;al., 2012</xref>) and TALOS-N (<xref ref-type="bibr" rid="B62">Shen and Bax, 2013</xref>) algorithms which indicate substantial (&#x3e;80 %) &#x3b1;-helical propensity for residues 289&#x2013;299 in both the SERBP1 149&#x2013;400 and 189&#x2013;400 constructs (<xref ref-type="sec" rid="s10">Supplementary Figure S4</xref>). Circular dichroic (CD) spectra of SERBP1 149&#x2013;400 and 189&#x2013;400 recorded to measure thermal denaturation have a similar appearance and contain features indicative of IDPs such as the strong negative transition at 200&#xa0;nm (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>). For both constructs, a negative transition at approximately 222&#xa0;nm becomes more negative as the temperature is increased from 20 to 80&#x00B0;C. The temperature gradient also reveals an isodichroic point at 212&#xa0;nm indicative of a two-state transition that could translate to exchange between partially ordered and completely disordered conformations (<xref ref-type="bibr" rid="B28">Greenfield, 2006</xref>). Deconvolution of these CD spectra to estimate helical content is complicated by the inherent contributions from polyproline II conformations that contribute to the observed transitions at 200 and 212&#xa0;nm (<xref ref-type="bibr" rid="B36">Kjaergaard and Poulsen, 2011</xref>). Taken together these data are consistent with the chemical shift analysis (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>), secondary structure, and disorder predictions <xref ref-type="fig" rid="F1">Figures 1B,C</xref> and indicate that SERBP1 is primarily disordered with some &#x3b1;-helical character.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Secondary structure of SERBP1 149&#x2013;400 and 189&#x2013;400. Secondary structure propensity calculated from backbone chemical shifts by the SSP algorithm for <bold>(A)</bold> SERBP1 149&#x2013;400 and <bold>(B)</bold> 189&#x2013;400. Gray boxes outline residues 289&#x2013;299, identified as having a high &#x3b1;-helical character. A cartoon representation of the &#x3b1;-helix and relative position of the RGG boxes (green) is shown above the plots. <bold>(C)</bold> CD spectra of SERBP1 189&#x2013;400 <bold>(right)</bold> and SERBP1 149&#x2013;400 <bold>(left)</bold> acquired at 10&#x00B0;C intervals from 20&#x00B0;C to 80&#x00B0;C.</p>
</caption>
<graphic xlink:href="fmolb-08-744707-g002.tif"/>
</fig>
<p>To further define the structural properties of SERBP1, we investigated the fast timescale dynamics of the truncation mutants by measuring the <sup>15</sup>N <italic>R</italic>
<sub>1</sub> and <italic>R</italic>
<sub>2</sub> relaxation rates, as well as the <sup>1</sup>H-<sup>15</sup>N heteronuclear NOE (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>; <xref ref-type="sec" rid="s10">Supplementary Figure S5</xref>). For the 189&#x2013;400 construct, the average <italic>R</italic>
<sub>1</sub> and <italic>R</italic>
<sub>2</sub> values are 1.5&#xa0;s<sup>&#x2212;1</sup> and 9.6&#xa0;s<sup>&#x2212;1</sup>, respectively, except for residues 289&#x2013;299 in the region identified as helical by SSP, which have average <italic>R</italic>
<sub>1</sub> and <italic>R</italic>
<sub>2</sub> of 1.2&#xa0;s<sup>&#x2212;1</sup> and 22.5&#xa0;s<sup>&#x2212;1</sup> respectively. We observed similar average <italic>R</italic>
<sub>1</sub> and <italic>R</italic>
<sub>2</sub> (1.5&#xa0;s<sup>&#x2212;1</sup> and 9.5&#xa0;s<sup>&#x2212;1</sup> respectively) along with variations in the same region (289&#x2013;299) for SERBP1 149&#x2013;400 (<xref ref-type="sec" rid="s10">Supplementary Figure S5</xref>). Average heteronuclear NOE values for both constructs were 0.4 with the residues in the 289&#x2013;299 stretch displaying values approaching 0.75, indicating the motions of these amino acids are more restricted than the rest of the chain. These data reveal that the two truncated proteins retain virtually identical dynamics and contain a stable &#x3b1;-helix comprising residues 289&#x2013;299, the stability of which seems to be independent of the RGG&#x20;boxes.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>
<sup>15</sup>N relaxation parameters of SERBP1 189&#x2013;400 including <bold>(A)</bold> <italic>R</italic>
<sub>1</sub> and <bold>(B)</bold> <italic>R</italic>
<sub>2</sub> rates, and <bold>(C)</bold> the <sup>1</sup>H-<sup>15</sup>N heteronuclear NOE plotted against the protein sequence. The dashed lines represent the average value for each experiment, also indicated in brackets. A cartoon representation of the &#x3b1;-helix identified from chemical shift information and relative position of the RGG boxes (green) is shown above the plots. The shaded boxes align the helical region and RGG box over all panels.</p>
</caption>
<graphic xlink:href="fmolb-08-744707-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>SERBP1 Behaves as a Compact, Monomeric IDP</title>
<p>Size exclusion chromatography (SEC), dynamic light scattering (DLS) and analytical ultracentrifugation (AUC) were employed to assess the oligomeric state of SERBP1 and to determine if the stable &#x3b1;-helix acts as a dimerization interface, as has previously been described for TAR DNA-binding protein (TDP-43) (<xref ref-type="bibr" rid="B18">Conicella et&#x20;al., 2016</xref>). At physiological conditions, SERBP1 189&#x2013;400 elutes at 14.7&#xa0;ml (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>), which, according to column calibration (data not shown) corresponds to a molecular weight of 51.6&#xa0;kDa, suggesting a possible dimerization of SERBP1 (the molecular weight of monomers is 23.7&#xa0;kDa) if SERBP1 were a globular, folded protein. However, due to their extended conformations, IDPs are expected to elute earlier in SEC corresponding to larger apparent molecular weights (<xref ref-type="bibr" rid="B71">Uversky, 2012</xref>). The SEC experiment was repeated in the presence of 2&#xa0;M of GdnHCl, resulting in an elution volume of 13.3&#xa0;ml, corresponding to a molecular weight of 95.9&#xa0;kDa (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). Similar behavior was observed for SERBP1 149&#x2013;400 which displayed elution volumes of 14.8 and 12.8&#xa0;ml in absence and in presence of 2&#xa0;M GdnHCl, respectively (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). If SERBP1 formed oligomers in the absence of GdnHCl, the elution volume should increase upon the addition GdnHCl, contrary to the observed decrease. These results suggest that SERBP1 becomes more extended, occupying a much larger steric volume in 2&#xa0;M GdnHCl than in physiological conditions.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Biophysical characterization of SERBP1 oligomer state in solution. Size exclusion chromatography profiles of <bold>(A)</bold> SERBP1 189&#x2013;400 and <bold>(B)</bold> SERBP1 149&#x2013;400, respectively, in the absence (solid) and presence (red) of 2&#xa0;M GdnHCl recorded at A<sub>280</sub>. <bold>(C)</bold> Size distribution histograms of the apparent hydrodynamic radius (<italic>R</italic>
<sub>h</sub>) derived from dynamic light scattering experiments of SERBP1 189&#x2013;400 in the absence (solid) and presence (dashed) of 2&#xa0;M GdnHCl. <bold>(D)</bold> Analytical ultracentrifugation sedimentation velocity coefficient profiles of SERBP1 189&#x2013;400 in the absence (solid) and presence (dashed) of 2&#xa0;M GdnHCl.</p>
</caption>
<graphic xlink:href="fmolb-08-744707-g004.tif"/>
</fig>
<p>To further assess the oligomeric state of SERBP1, DLS was used to measure the apparent hydrodynamic radius (<italic>R</italic>
<sub>h</sub>) at physiological conditions and in the presence of 2&#xa0;M GdnHCl (<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref>). A mean <italic>R</italic>
<sub>h</sub> estimation of 3.9 and 4.4&#xa0;nm under physiological and denaturing conditions, respectively, was obtained for SERBP1 189&#x2013;400. Notably, the polydispersity in the presence of GdnHCl was &#x223c;30%, higher than the &#x223c;13% that was observed under non-denaturing conditions. The small relative difference in <italic>R</italic>
<sub>h</sub> in the presence and absence of GdnHCl indicates that SERBP1 is a monomer at physiological conditions, consistent with the SEC results, adopting a conformation that is more compact than a fully disordered chain. The theoretical <italic>R</italic>
<sub>h</sub> value, calculated by the method proposed by Marsh and Forman-Kay (<xref ref-type="bibr" rid="B47">Marsh and Forman-Kay, 2010</xref>) was 3.8&#xa0;nm, in very good agreement with the experimentally measured value of 3.9&#xa0;nm, further evidence that SERBP1 is monomeric at these conditions (<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref>). Finally, AUC experiments were conducted on SERBP1 189&#x2013;400 in absence and presence of 2&#xa0;M GdnHCl (<xref ref-type="fig" rid="F4">Figure&#x20;4D</xref>). The fitted sedimentation coefficient was lower (1.3&#x20;<italic>vs.</italic> 1.9) and the frictional ratio was higher (2.2&#x20;<italic>vs.</italic> 1.8, not shown) in presence of GdnHCl, indicating SERBP1 189&#x2013;400 is more compact under physiological conditions than a fully extended polypeptide chain, and that it becomes less compact in denaturing conditions. Similar results were obtained for SERBP1 149&#x2013;400 with a lower sedimentation coefficient (1.5&#x20;<italic>vs.</italic> 2.2) and a higher frictional ratio (2.1&#x20;<italic>vs.</italic> 1.7, not shown) in the presence vs. absence of 2&#xa0;M GdnHCl respectively (<xref ref-type="sec" rid="s10">Supplementary Figure S6</xref>). These observations are consistent with the average <italic>R</italic>
<sub>2</sub> rates recorded for both constructs, (&#x223c;9.5&#xa0;s<sup>&#x2212;1</sup>) which are faster than expected for proteins that would preferentially exist in extended conformations (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>; <xref ref-type="sec" rid="s10">Supplementary Figure S5B</xref>). Together, these data are highly consistent and reveal that SERBP1 is monomeric under the experimental conditions used here, adopting conformations that are more compact than a fully extended polymer.</p>
</sec>
<sec id="s3-4">
<title>SERBP1 Interacts With Guanine-Rich RNA</title>
<p>SERBP1 is thought to be an important regulator of many different mRNAs although the structural details of RNA recognition remain unclear. Previously, the RNAcompete assay defined 5&#x2032;-GCGCGGG-3&#x2032; as the SERBP1 consensus binding motif and subsequently it was shown that an RNA oligonucleotide containing this sequence binds full-length SERBP1 with sub-micromolar affinity (<xref ref-type="bibr" rid="B38">Kosti et&#x20;al., 2020</xref>). Here, heteronuclear NMR was used to study the interaction between SERBP1 189&#x2013;400 and the 7-mer RNA oligonucleotide. A series of <sup>1</sup>H,<sup>15</sup>N heteronuclear single quantum correlation (HSQC) spectra of SERBP1 189&#x2013;400 were acquired in the presence of increasing concentrations of the 7-mer RNA (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>). Overall, the spectra remain similar in response to increasing concentrations of the 7-mer indicating the RNA ligand does not induce folding of SERBP1, a phenomenon that has been observed for other IDPs (<xref ref-type="bibr" rid="B67">Sugase et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B69">Tompa and Fuxreiter, 2008</xref>; <xref ref-type="bibr" rid="B61">Shammas et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B8">Bonetti et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B55">Robustelli et&#x20;al., 2020</xref>). However, some peaks display strong chemical shift perturbations (CSP), such as A395, S394, and V398, indicating these residues interact strongly with the RNA (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>, insets). Additionally, glycine peaks (e.g., G363, G366) belonging to the RGG box broaden significantly as the ligand concentration increases, likely due to exchange between the free and the bound forms at an intermediate rate on the NMR time scale. These observations lead to the proposal that electrostatic interactions occur between the positively charged arginine residues of the RGG box and the negatively charged phosphates of the RNA backbone. This encounter complex could then be stabilized by interactions with residues N383-V398, especially with T388 and S394 since serine and threonine are excellent hydrogen bond donors. Plotting the maximal CSP (&#x394;&#x3b4;<sub>max</sub>) against the protein sequence reveals that the RNA interacts with residues spanning from the second RGG box to the C-terminus of SERBP1, with some &#x394;&#x3b4;<sub>max</sub> higher than 0.1&#xa0;ppm (e.g., N383, T388, S394) (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>). If an initial SERBP1:RNA encounter complex forms through charge-charge interactions, the complementary RNA sequence (5&#x2032;-AUAUAAA-3&#x2032;) may induce similar broadening in the RGG-specific glycine residues. No specific CSPs were observed in the C-terminal region of the SERBP1 189&#x2013;400 (<xref ref-type="fig" rid="F5">Figure&#x20;5C</xref>), and broadening of resonances belonging to the RGG box was not detected (<xref ref-type="sec" rid="s10">Supplementary Figure S7</xref>). Some CSPs higher than 0.05&#xa0;ppm are randomly dispersed along the chain, but these are more likely indicative of non-specific protein-RNA interactions. Taken together, these data reveal that further experimentation is required to fully elucidate the nature of the SERBP1 RNA recognition and complex formation.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Binding of SERBP1 189&#x2013;400 to a 7-mer RNA oligonucleotide measured by chemical shift perturbations (CSP). <bold>(A)</bold> Overlay of the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra of SERBP1 in absence (blue) and presence (red) of 1:1.6&#xa0;molar ratio of the 5&#x2032;-GCGCGGG-3&#x2032; RNA 7-mer. Only the two titration points are shown to highlight the broadening of glycine residues observed upon addition of RNA ligand. The insets show the full titration series of peaks that shift significantly. A cartoon representation of the &#x3b1;-helix identified from chemical shift information and relative position of the RGG boxes (green) is shown above the plots. The shaded box aligns the RGG box over all panels. <bold>(B)</bold> Maximum CSP (&#x394;&#x3b4;<sub>max</sub>) induced by the RNA G-quartet ligand binding plotted against SERBP1 189&#x2013;400 sequence. The dashed line represents the mean standard deviation of &#x394;&#x3b4;<sub>max</sub> for all peaks, shifts above this threshold are considered significant. <bold>(C)</bold> Maximum CSP (&#x394;&#x3b4;<sub>max</sub>) of a negative control RNA ligand (5&#x2032;-AUAUAAA-3&#x2032;) plotted against SERBP1 189&#x2013;400 sequence. The dashed line represents the mean standard deviation of &#x394;&#x3b4;<sub>max</sub> for all peaks. Normalized intensities of the <sup>1</sup>H,<sup>15</sup>N-HSQC peaks of SERBP1 189&#x2013;400 plotted as a function of the protein sequence, in <bold>(D)</bold> the absence and <bold>(E)</bold> presence of 1:1.6 molar ratio of protein to the RNA 7-mer G-quartet ligand. Dashed lines are the same in both panels and represent the average intensity of SERBP1 peaks in the absence of RNA.</p>
</caption>
<graphic xlink:href="fmolb-08-744707-g005.tif"/>
</fig>
<p>The relative peak intensities of SERBP1 residues before and after titration were plotted as a function of the amino acid sequence to gain insight into the global effect of the RNA binding on the protein. <xref ref-type="fig" rid="F5">(Figures 5D,E</xref>). Uniform broadening of the peaks along the entire protein sequence was observed upon the addition of stoichiometric quantities of the 7-mer RNA, with the exception of residues 250&#x2013;285, that precede the &#x3b1;-helix. Notably, these residues retain approximately equal intensities in the absence or presence of the RNA (compare <xref ref-type="fig" rid="F5">Figures 5D,E</xref>), suggesting they remain unaffected by interactions with RNA. This region has lower than average heteronuclear NOE (&#x223c;0.25) and <italic>R</italic>
<sub>2</sub> rates (&#x223c;7&#xa0;s<sup>&#x2212;1</sup>) indicating that these residues are more dynamic compared to the rest of the protein and remain mobile in the presence of RNA (<xref ref-type="fig" rid="F3">Figures 3B,C</xref>). Finally, no CSPs or peak broadening beyond the uniform broadening described above were observed for residues 289&#x2013;299 that comprise the &#x3b1;-helix indicating that this region is not involved in recognition or binding of the RNA 7-mer.</p>
</sec>
<sec id="s3-5">
<title>SERBP1 Phase Separation is Inhibited by the Presence of Salt and Modulated by RNA</title>
<p>Intrinsically disordered RBPs are overrepresented in the group of proteins that are known to participate in biomolecular condensates and undergo LLPS (<xref ref-type="bibr" rid="B12">Burke et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B24">Elbaum-Garfinkle et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B6">Boeynaems et&#x20;al., 2017</xref>). The phase separation properties of the SERBP1 149&#x2013;400 and 189&#x2013;400 constructs were assayed using droplet formation assays and fluorescence recovery after photobleaching (FRAP). At neutral pH, SERBP1 149&#x2013;400 readily phase separates at a concentration of 10&#xa0;&#xb5;M in absence of NaCl. The addition of NaCl abrogates SERBP1 phase separation with noticeably smaller and fewer droplets forming in the presence of 50&#xa0;mM NaCl and complete dissipation at 150&#xa0;mM NaCl (<xref ref-type="sec" rid="s10">Supplementary Figure S8A</xref>). Conversely, SERBP1 189&#x2013;400 does not phase separate at all under the same physiochemical conditions (<xref ref-type="sec" rid="s10">Supplementary Figure S8B</xref>). Increasing NaCl concentrations (50&#x2013;1000&#xa0;mM) had no effect on the LLPS characteristics of SERBP1 189&#x2013;400. Since the main difference between the two constructs is the N-terminal RGG box, it is reasonable to conclude that the RGG boxes promote phase separation of SERBP1, consistent with what has been described for other RGG-containing RBPs (<xref ref-type="bibr" rid="B16">Chong et&#x20;al., 2018</xref>).</p>
<p>Given the observed effects of NaCl on phase separation of SERBP1, the effect of RNA was also tested. In this assay, 150&#xa0;mM NaCl, 13 % glycerol, and 13% PEG3000 were included in the droplet formation buffer with 12&#xa0;&#xb5;M SERBP1 149&#x2013;400 or SERBP1 189&#x2013;400 and increasing concentrations of torula yeast RNA (<xref ref-type="fig" rid="F6">Figures 6A,B</xref>). Contrary to the effect of NaCl, RNA promoted phase separation of SERBP1 189&#x2013;400&#xa0;at concentrations as low as 0.05&#xa0;mg/&#xa0;ml RNA (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>). Under the three RNA concentrations tested (0.05, 0.2, and 0.4&#xa0;mg/&#xa0;ml), the observed average droplet size for SERBP1 189&#x2013;400 remained consistent at &#x223c;12&#xa0;&#x3bc;m<sup>2</sup> (<xref ref-type="fig" rid="F6">Figure&#x20;6D</xref>). At the same protein concentration, phase separation of SERBP1 149&#x2013;400 was promoted by the presence of glycerol and PEG3000 (compare the 0&#xa0;mg/&#xa0;ml panels in <xref ref-type="fig" rid="F6">Figures 6 A,B</xref>) while droplet size strongly correlated to the RNA concentration (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>). At no added RNA or 0.05&#xa0;mg/&#xa0;ml RNA, the average observed droplet size for SERBP1 149&#x2013;400 was &#x223c;50&#xa0;&#x3bc;m<sup>2</sup>. The average droplet size significantly decreased to &#x223c;20&#xa0;&#x3bc;m<sup>2</sup> as the RNA concentration increased to 0.2 and 0.4&#xa0;mg/&#xa0;ml (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>). This trend held when the experiment was repeated with 6&#xa0;&#xb5;M SERBP1 149&#x2013;400 albeit the average observed droplet size was lower, ranging from 10&#xa0;&#x3bc;m<sup>2</sup> without RNA to 2&#xa0;&#x3bc;m<sup>2</sup> at an RNA concentration of 0.4&#xa0;mg/&#xa0;ml (<xref ref-type="sec" rid="s10">Supplementary Figure S9</xref>). RNA modulates SERBP1 phase separation, promoting phase separation for SERBP1 189&#x2013;400 under non-permissive conditions, as well as altering the droplet characteristics formed from SERBP1 149&#x2013;400. While the influence of crowding agents cannot be separated from the contribution of the RGG boxes to phase separation in these experiments, taken together these results show that the RGG boxes are important for SERBP1 LLPS, which likely proceeds through a charge-mediated mechanism.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Phase separation assays of SERBP1 149&#x2013;400 and SERBP1 189&#x2013;400. Effect of RNA on the LLPS propensity of 12&#xa0;&#xb5;M <bold>(A)</bold> SERBP1 149&#x2013;400 or <bold>(B)</bold> SERBP1 189&#x2013;400 in buffer containing 13 % (v/v) glycerol and 13 % (w/v) PEG3000. Torula yeast RNA was titrated into SERBP1 protein solutions to final concentrations ranging from 0 to 0.4&#xa0;mg/&#xa0;ml. The average droplet sizes (&#xb5;m<sup>2</sup>) shown for <bold>(C)</bold> SERBP1 149&#x2013;400 and <bold>(D)</bold> SERBP1 189&#x2013;400 were derived from three independent images. Normalized fluorescence recovery after photobleaching (FRAP) profiles of 12&#xa0;&#xb5;M SERBP1 149&#x2013;400 in the <bold>(E)</bold> absence or <bold>(F)</bold> presence of 0.05&#xa0;mg/&#xa0;ml torula yeast RNA. Dashed line indicates average the fluorescence before photobleaching.</p>
</caption>
<graphic xlink:href="fmolb-08-744707-g006.tif"/>
</fig>
<p>The liquid -like nature of the condensates formed by SERBP1 149&#x2013;400 in the presence and absence of RNA were probed using FRAP experiments (<xref ref-type="fig" rid="F6">Figure&#x20;6D</xref>). In the absence of RNA, the recovery of fluorescence plateaus at &#x223c;70&#xa0;s, while in the presence of 0.05&#xa0;mg/&#xa0;ml of RNA, the fluorescence intensity recovers faster, reaching a plateau in &#x223c;40&#xa0;s. The faster recovery of fluorescence in the presence of RNA is indicative of faster diffusion and hence more dynamic droplets. These results support the droplet formation assays suggesting that the two RGG boxes might interact synergistically with the RNA to modulate the condensate behavior of SERBP1. Further investigation will be necessary to decipher the molecular mechanisms of SERBP1&#x20;LLPS.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>SERBP1 was initially identified as a hyaluronic acid binding protein in biochemical pull-down studies using hyaluronic acid as bait (<xref ref-type="bibr" rid="B31">Heaton et&#x20;al., 2001</xref>). The pattern of expression in normal tissue of the two known human hyaluronic acid binding proteins, HABP2 and HABP4 are different than SERBP1. HABP2 is predominantly found in the liver, while expression of HABP4 is the opposite of what was found for SERBP1 with high expression in all regions of the brain and very low expression in immortalized cells (<xref ref-type="bibr" rid="B38">Kosti et&#x20;al., 2020</xref>). HABP4 binds mRNA and is known to interact with Receptor of activated protein C kinase (RACK1), a protein implicated in mRNA splicing and translation, although the significance of these associations is unknown (<xref ref-type="bibr" rid="B34">Huang et&#x20;al., 2000</xref>; <xref ref-type="bibr" rid="B51">Nery et&#x20;al., 2004</xref>). Similarly, SERBP1 was recently identified as a binding partner of RACK1 (<xref ref-type="bibr" rid="B7">Bolger, 2017</xref>), an interaction that was proposed to play a role in ribosomal composition and translation regulation. Thus, it is possible that although SERBP1 and HABP4 share significant sequence homology, the similarities are coincidental and represent an example of convergent or parallel evolution (<xref ref-type="bibr" rid="B65">Storz, 2016</xref>).</p>
<p>Sequence alignments with non-vertebrate SERBP1 homologues revealed five broadly defined regions of homology that roughly correlate with predicted SERBP1 ordered structure (compare dashed boxes in <xref ref-type="fig" rid="F1">Figures 1C,D</xref>). In particular, chemical shift-derived secondary structure propensity, and CD measurements support predictions that SERBP1 is not entirely disordered but rather contains stable native structure in the form of an &#x3b1;-helix (residues 289&#x2013;299), a structural feature common to many IDPs (<xref ref-type="bibr" rid="B40">Lee et&#x20;al., 2012b</xref>), in a stretch of residues that are highly conserved among vertebrate and invertebrate sequences. The &#x3b1;-helix appears stable in both the 189&#x2013;400 and 149&#x2013;400 constructs and displays faster than expected transverse (<italic>R</italic>
<sub>2</sub>) relaxation rates on the order of 20&#x2013;25&#xa0;s<sup>&#x2212;1</sup>. These observations suggested the &#x3b1;-helix might be stabilized by intra- or intermolecular associations, or possibly mediate homodimerization. Such behavior has been described for TDP-43, a protein involved amyotrophic lateral sclerosis, whose disordered C-terminus domain contains an &#x3b1;-helix involved in protein-protein homodimerization and liquid-liquid phase separation (<xref ref-type="bibr" rid="B18">Conicella et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B44">Lim et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B17">Conicella et&#x20;al., 2020</xref>). Therefore, intramolecular interactions of SERBP1 may contribute to the stability of the helix and promote preferential sampling of compact conformations, as observed for other IDPs (<xref ref-type="bibr" rid="B47">Marsh and Forman-Kay, 2010</xref>). Alternatively, the &#x3b1;-helix, or the other conserved domains might act as molecular recognition motifs, mediating associations with various biomolecular partners, through folding-upon-binding mechanisms (<xref ref-type="bibr" rid="B67">Sugase et&#x20;al., 2007</xref>). Relaxation dispersion experiments did not reveal exchange with alternate SERBP1 conformers, yet these experiments do not rule out this possibility since the exchange timescale may be inaccessible for CPMG-based experiments. Paramagnetic relaxation enhancements, filtered NOE, or off-resonance <italic>R</italic>
<sub>1&#x3c1;</sub> experiments maybe more suitable to probe SERBP1 conformational exchange and are an active area of investigation.</p>
<p>SERBP1 is a multifunctional mRNA binding protein that has roles in regulating the expression of several mRNAs yet despite clear evidence of RNA binding (<xref ref-type="bibr" rid="B31">Heaton et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B2">Anger et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B50">Muto et&#x20;al., 2018</xref>) it does not seem to possess any canonical RNA binding motifs, such as RRMs, zinc-fingers or KH domains, which are predominant in other RNA-binding proteins (<xref ref-type="bibr" rid="B46">Maris et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B72">Valverde et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B19">Cook et&#x20;al., 2015</xref>). The recognizable RNA-binding features of SERBP1 are two RG/RGG repeat regions comprising residues 165&#x2013;184 and 366&#x2013;386. CSPs and differential peak broadening suggest that the G-quartet RNA interaction spans the C-terminal RGG box and incorporates adjacent residues. Mutagenesis experiments will be useful to further define the role of the RGG box as well as uncover the source of the specificity of guanines over the other nucleotides (<xref ref-type="fig" rid="F5">Figures 5B,C</xref>). Furthermore, these results are consistent with recent observations that some RBPs, particularly intrinsically disordered RBPs, can interact with RNA without the presence of specific folded RNA-binding domains (<xref ref-type="bibr" rid="B14">Castello et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B35">J&#xe4;rvelin et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B33">Hentze et&#x20;al., 2018</xref>). As described here for SERBP1, RGG repeats of this class of RBP seem to play an important role in mediating interactions with RNA (<xref ref-type="bibr" rid="B16">Chong et&#x20;al., 2018</xref>). For example, the RGG box of fragile X mental retardation protein (FMRP) was shown to interact with G-quadruplex forming RNA sequences (<xref ref-type="bibr" rid="B21">Darnell et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B54">Phan et&#x20;al., 2011</xref>). Since SERBP1 was recently shown to bind G-quadruplexes (<xref ref-type="bibr" rid="B66">Su et&#x20;al., 2021</xref>), it is important to elucidate the binding mode, the relative contribution of both RGG boxes, and any involvement of other conserved sequence motifs. A particularly important question to investigate is if SERBP1 actively stabilizes or destabilizes G-quadruplexes.</p>
<p>Proximity labeling approaches have identified SERBP1 interactions with myriad RBPs involved in mRNA regulation, stabilization, and splicing, translation, neurogenesis, synaptogenesis, and ribosome binding such as CAPRIN1, EIF4B, FXR1, LARP1, PABPC4, SYNCRIP, and YTHDF3 among others (<xref ref-type="bibr" rid="B77">Youn et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B53">Pedley et&#x20;al., 2020</xref>). Similar to SERBP1, the subcellular localization of many of these proteins is controlled by arginine methylation, enabling them to shuttle between the nucleus and cytoplasm (<xref ref-type="bibr" rid="B41">Lee et&#x20;al., 2012a</xref>). Indeed, many of these proteins localize to stress granules or other subcellular biomolecular condensates (<xref ref-type="bibr" rid="B42">Lee et&#x20;al., 2014</xref>), and likewise, SERBP1 was shown here to undergo LLPS mediated by its RGG boxes. SERPB1 149&#x2013;400 readily phase separates in low ionic strength buffers at neutral pH while the 189&#x2013;400 construct does not, highlighting the importance of the presence of both RGG boxes to promote LLPS (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>). The response to increasing ionic strength indicate that electrostatic interactions are an important mechanism mediating the transient self-associative contacts responsible for condensate formation as has been described for the BRD4-IDR (<xref ref-type="bibr" rid="B56">Sabari et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B30">Han et&#x20;al., 2020</xref>) or Ddx4 (<xref ref-type="bibr" rid="B9">Brady et&#x20;al., 2017</xref>). Indeed, LLPS of protein-RNA complexes has recently been described as a way of regulating biological processes such as transcriptional or translational events (<xref ref-type="bibr" rid="B29">Han et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B5">Berry et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B64">Smith et&#x20;al., 2016</xref>), and in some cases, RNA has been proposed to slow the formation of droplets of aggregation-prone prion-like proteins (<xref ref-type="bibr" rid="B45">Maharana et&#x20;al., 2018</xref>). While RNA was shown to impact the LLPS properties of SERBP1, the effect of specific RNA structures like stem-loops or G-quadruplexes on SERBP1 condensate formation will require further investigation. Additionally, the &#x3b1;-helix in SERBP1 may contribute to electrostatic contacts important for LLPS since several residues comprising the &#x3b1;-helix are charged (E287, D291, E292, K294, D300).</p>
<p>Genomic studies indicate SERBP1 has a significant role in the one-carbon metabolism cycle and was implicated in synaptogenesis and neuronal development (<xref ref-type="bibr" rid="B38">Kosti et&#x20;al., 2020</xref>). These pathways seem to be important in the development and progression of GBM. Indeed, SERBP1 is overexpressed in the brains of GBM patients and is negatively correlated with a favorable prognosis (<xref ref-type="bibr" rid="B39">Kunkle et&#x20;al., 2013</xref>). Involvement of SERBP1 in these pathways may be through regulation of mRNA translation, transcription or splicing or through a combination of these functions. For example, SERBP1 was identified bound to the mRNA tunnel in the structures of inactive 80&#xa0;S ribosomes reported by different groups (<xref ref-type="bibr" rid="B2">Anger et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B10">Brown et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B50">Muto et&#x20;al., 2018</xref>), and was hypothesized to aid in translational control by negatively regulating ribosomal activity. The significance of these discoveries is not fully understood but may be related to a feedback cycle linking mRNA splicing to transcription mediated by RBPs like SERBP1. Recent work revealed a similar function for the SARS-CoV-2 protein Nsp1, which inserts its C-terminal domain into the ribosome mRNA channel, interrupting host transcriptional regulation (<xref ref-type="bibr" rid="B58">Schubert et&#x20;al., 2020</xref>). Further, Zhang et&#x20;al., found that SARS-CoV-2 also dysregulates One-carbon metabolism by increasing <italic>de novo</italic> purine synthesis and glycolysis (<xref ref-type="bibr" rid="B78">Zhang et&#x20;al., 2021</xref>), a mechanism that was recently described for SERBP1 in GBM metabolism regulation (<xref ref-type="bibr" rid="B38">Kosti et&#x20;al., 2020</xref>). These findings require further investigation to determine whether this is a specific strategy involving host mimicry of SERBP1 or simply a consequence of the general viral infection strategy of disrupting host translational regulation.</p>
<p>In summary, SERBP1 is an atypical RBP lacking known RNA recognition motifs and has multifunctional roles in translation and mRNA regulation and modulates One-carbon metabolism, neuronal differentiation and synaptogenesis. We identified the G-quartet RNA binding site on SERBP1 using NMR and present several lines of evidence such as conserved secondary structure and semi-compact conformations that suggest SERBP1 also recognizes higher-order RNA structures including stem-loops and G-quadraplexes. Current efforts are focused on identifying SERBP1 interactions with G-quadruplexes and assaying for folding or destabilizing activity. Additionally, the partially folded and compact nature of SERBP1 may be indicative of pre-encounter conformations important for recognition and binding to other biomolecular targets. Future studies will examine the conformational dynamics of the &#x3b1;-helix and neighboring regions as potential binding sites for the myriad identified binding partners.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will&#x20;be&#x20;made available by the authors, without undue reservation. The expression plasmid encoding SERBP1 149-400 was deposited with Addgene (176516) and the backbone resonance assignments are available from the Biological Magnetic Resonance Bank (51080).</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>AB made NMR samples, collected, processed, and interpreted data, wrote the manuscript, AM-R preformed the droplet formation assays, XX made expression constructs, and purified protein, ES collected, processed and analyzed the AUC experiments, LP performed phylogenetic analysis, wrote the manuscript, conceptualized the study and obtained funding, DL collected and processed data, wrote the manuscript, conceptualized the study and obtained funding, all authors contributed to editing manuscript. All authors have read and approved the manuscript for publication.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>DL is a St. Baldrick&#x2019;s Scholar and acknowledges the support of the St. Baldrick&#x2019;s Foundation (634706).This study was funded in part by the Max and Minnie Tomerlin Voelcker Fund (Voelcker Foundation Young Investigator Grant to DL), the Welch Foundation (AQ-2001&#x2013;20190330 to DL), the Cancer Prevention and Research Institute of Texas (RP200595 to LP), and a Mays Cancer Center Pilot Grant (to LP). EES was supported by a CPRIT Research Training Award (RP170345). This work is based upon research conducted in the Structural Biology Core Facilities, a part of the Institutional Research Cores at the University of Texas Health Science Center at San Antonio supported by the Office of the Vice President for Research and the Mays Cancer Center Drug Discovery and Structural Biology Shared Resource (NIH P30 CA05417X4).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors thank Dr. Kristin Cano for NMR technical assistance and members of the DL and LP laboratories for valuable discussions.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.744707/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2021.744707/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname>
<given-names>J.-W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Baek</surname>
<given-names>S.-J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>SERBP1 Affects Homologous Recombination-Mediated DNA Repair by Regulation of CtIP Translation during S Phase</article-title>. <source>Nucleic Acids Res.</source> <volume>43</volume> (<issue>13</issue>), <fpage>6321</fpage>&#x2013;<lpage>6333</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv592</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anger</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Armache</surname>
<given-names>J.-P.</given-names>
</name>
<name>
<surname>Berninghausen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Habeck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Subklewe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>D. N.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Structures of the Human and Drosophila 80S Ribosome</article-title>. <source>Nature</source> <volume>497</volume> (<issue>7447</issue>), <fpage>80</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1038/nature12104</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antos</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Ingram</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pishesha</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Truttmann</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Ploegh</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Site-Specific Protein Labeling via Sortase-Mediated Transpeptidation</article-title>. <source>Curr. Protoc. Protein Sci.</source> <volume>89</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/cpps.38</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baudin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Libich</surname>
<given-names>D. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The 1H, 15N and 13C Resonance Assignments of the C-Terminal Domain of Serpine mRNA Binding Protein 1 (SERBP1)</article-title>. <source>J.&#x20;Biomol. NMR Assignments</source>. <comment>In Press</comment>. <pub-id pub-id-type="doi">10.1007/s12104-021-10046-3</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berry</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Vaidya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Haataja</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brangwynne</surname>
<given-names>C. P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>RNA&#x20;Transcription Modulates Phase Transition-Driven Nuclear Body Assembly</article-title>. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>112</volume> (<issue>38</issue>), <fpage>E5237</fpage>&#x2013;<lpage>E5245</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1509317112</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boeynaems</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bogaert</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Konijnenberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Timmerman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Volkov</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics</article-title>. <source>Mol. Cel.</source> <volume>65</volume> (<issue>6</issue>), <fpage>1044</fpage>&#x2013;<lpage>1055</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2017.02.013</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolger</surname>
<given-names>G. B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The RNA-Binding Protein SERBP1 Interacts Selectively with the Signaling Protein RACK1</article-title>. <source>Cell Signal.</source> <volume>35</volume>, <fpage>256</fpage>&#x2013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2017.03.001</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonetti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Troilo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Brunori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Longhi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gianni</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>How Robust Is the Mechanism of Folding-Upon-Binding for an Intrinsically Disordered Protein?</article-title> <source>Biophysical J.</source> <volume>114</volume> (<issue>8</issue>), <fpage>1889</fpage>&#x2013;<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2018.03.017</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brady</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Farber</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Sekhar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bah</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Structural and Hydrodynamic Properties of an Intrinsically Disordered Region of a Germ Cell-Specific Protein on Phase Separation</article-title>. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>114</volume> (<issue>39</issue>), <fpage>E8194</fpage>&#x2013;<lpage>E8203</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1706197114</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Structures of Translationally Inactive Mammalian Ribosomes</article-title>. <source>eLife</source> <volume>7</volume>, <fpage>e40486</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.40486</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buchan</surname>
<given-names>D. W. A.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D. T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The PSIPRED Protein Analysis Workbench: 20&#x20;Years on</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume> (<issue>W1</issue>), <fpage>W402</fpage>&#x2013;<lpage>W407</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz297</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burke</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Janke</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Rhine</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Fawzi</surname>
<given-names>N. L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Residue-by-Residue View of <italic>In Vitro</italic> FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II</article-title>. <source>Mol. Cel.</source> <volume>60</volume> (<issue>2</issue>), <fpage>231</fpage>&#x2013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.006</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camilloni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>De Simone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vranken</surname>
<given-names>W. F.</given-names>
</name>
<name>
<surname>Vendruscolo</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Determination of Secondary Structure Populations in Disordered States of Proteins Using Nuclear Magnetic Resonance Chemical Shifts</article-title>. <source>Biochemistry</source> <volume>51</volume> (<issue>11</issue>), <fpage>2224</fpage>&#x2013;<lpage>2231</lpage>. <pub-id pub-id-type="doi">10.1021/bi3001825</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castello</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Frese</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Horos</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alleaume</surname>
<given-names>A.-M.</given-names>
</name>
<name>
<surname>Foehr</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Comprehensive Identification of RNA-Binding Domains in Human Cells</article-title>. <source>Mol. Cel</source>. <volume>63</volume> (<issue>4</issue>), <fpage>696</fpage>&#x2013;<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2016.06.029</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chemes</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Alonso</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>Noval</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>de Prat-Gay</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Circular Dichroism Techniques for the Analysis of Intrinsically Disordered Proteins and Domains</article-title>. <source>Methods Mol. Biol.</source> <volume>895</volume>, <fpage>387</fpage>&#x2013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-927-3_22</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Vernon</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Forman-Kay</surname>
<given-names>J.&#x20;D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>RGG/RG Motif Regions in RNA Binding and Phase Separation</article-title>. <source>J.&#x20;Mol. Biol.</source> <volume>430</volume> (<issue>23</issue>), <fpage>4650</fpage>&#x2013;<lpage>4665</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2018.06.014</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conicella</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Dignon</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Zerze</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>D&#x2019;Ordine</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>TDP-43 &#x3b1;-helical Structure Tunes Liquid-Liquid Phase Separation and Function</article-title>. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>117</volume> (<issue>11</issue>), <fpage>5883</fpage>&#x2013;<lpage>5894</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1912055117</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conicella</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Zerze</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Mittal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fawzi</surname>
<given-names>N. L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>ALS Mutations Disrupt Phase Separation Mediated by &#x3b1;-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain</article-title>. <source>Structure</source> <volume>24</volume> (<issue>9</issue>), <fpage>1537</fpage>&#x2013;<lpage>1549</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2016.07.007</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cook</surname>
<given-names>K. B.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>Q. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>High-Throughput Characterization of Protein-RNA Interactions</article-title>. <source>Brief. Funct. Genomics</source> <volume>14</volume> (<issue>1</issue>), <fpage>74</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1093/bfgp/elu047</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>&#xc2;.</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Vidigal</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Meirelles</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Bressan</surname>
<given-names>G. C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Ki-1/57 and CGI-55 Ectopic Expression Impact Cellular Pathways Involved in Proliferation and Stress Response Regulation</article-title>. <source>Biochim. Biophys. Acta (Bba) - Mol. Cel Res.</source> <volume>1843</volume> (<issue>12</issue>), <fpage>2944</fpage>&#x2013;<lpage>2956</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.08.016</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darnell</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>K. B.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Darnell</surname>
<given-names>R. B.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function</article-title>. <source>Cell</source> <volume>107</volume> (<issue>4</issue>), <fpage>489</fpage>&#x2013;<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(01)00566-9</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delaglio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Grzesiek</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vuister</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pfeifer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bax</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>NMRPipe: A Multidimensional Spectral Processing System Based on UNIX Pipes</article-title>. <source>J.&#x20;Biomol. NMR</source> <volume>6</volume> (<issue>3</issue>), <fpage>277</fpage>&#x2013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1007/BF00197809</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delaglio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hoch</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Arbogast</surname>
<given-names>L. W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Non-Uniform Sampling for All: More NMR Spectral Quality, Less Measurement Time</article-title>. <source>Am. Pharm. Rev.</source> <volume>20</volume> (<issue>4</issue>), <fpage>339681</fpage>. </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbaum-Garfinkle</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Szczepaniak</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. C.-H.</given-names>
</name>
<name>
<surname>Eckmann</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Myong</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>The Disordered P Granule Protein LAF-1 Drives Phase Separation into Droplets with Tunable Viscosity and Dynamics</article-title>. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>112</volume> (<issue>23</issue>), <fpage>7189</fpage>&#x2013;<lpage>7194</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1504822112</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Estevez-Ordonez</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gessler</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vicario</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chagoya</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>SUMOylation in Glioblastoma: A Novel Therapeutic Target</article-title>. <source>Int. J.&#x20;Mol. Sci.</source> <volume>20</volume> (<issue>8</issue>), <fpage>1853</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20081853</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Go</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>J.&#x20;D. R.</given-names>
</name>
<name>
<surname>Rajasekharan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rathod</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hesketh</surname>
<given-names>G. G.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>K. T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>A Proximity-Dependent Biotinylation Map of a Human Cell</article-title>. <source>Nature</source> <volume>595</volume> (<issue>7865</issue>), <fpage>120</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03592-2</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gracheva</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Elgin</surname>
<given-names>S. C. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Drosophila RISC Component VIG and its Homolog Vig2 Impact Heterochromatin Formation</article-title>. <source>PLoS One</source> <volume>4</volume> (<issue>7</issue>), <fpage>e6182</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0006182</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenfield</surname>
<given-names>N. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Using Circular Dichroism Spectra to Estimate Protein Secondary Structure</article-title>. <source>Nat. Protoc.</source> <volume>1</volume> (<issue>6</issue>), <fpage>2876</fpage>&#x2013;<lpage>2890</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.202</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Mirzaei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Cell-Free Formation of RNA Granules: Bound RNAs Identify Features and Components of Cellular Assemblies</article-title>. <source>Cell</source> <volume>149</volume> (<issue>4</issue>), <fpage>768</fpage>&#x2013;<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.04.016</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Jaganathan</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Roles of the BRD4 Short Isoform in Phase Separation and Active Gene Transcription</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>27</volume> (<issue>4</issue>), <fpage>333</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1038/s41594-020-0394-8</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heaton</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Dlakic</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Dlakic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gelehrter</surname>
<given-names>T. D.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Identification and cDNA Cloning of a Novel RNA-Binding Protein that Interacts with the Cyclic Nucleotide-Responsive Sequence in the Type-1 Plasminogen Activator Inhibitor mRNA</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>276</volume> (<issue>5</issue>), <fpage>3341</fpage>&#x2013;<lpage>3347</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M006538200</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hendriks</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>D&#x27;Souza</surname>
<given-names>R. C. J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Verlaan-de Vries</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vertegaal</surname>
<given-names>A. C. O.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Uncovering Global SUMOylation Signaling Networks in a Site-Specific Manner</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>21</volume> (<issue>10</issue>), <fpage>927</fpage>&#x2013;<lpage>936</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2890</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hentze</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Castello</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schwarzl</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Preiss</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A Brave New World of RNA-Binding Proteins</article-title>. <source>Nat. Rev. Mol. Cel Biol.</source> <volume>19</volume> (<issue>5</issue>), <fpage>327</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2017.130</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Grammatikakis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yoneda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Toole</surname>
<given-names>B. P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Molecular Characterization of a Novel Intracellular Hyaluronan-Binding Protein</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>275</volume> (<issue>38</issue>), <fpage>29829</fpage>&#x2013;<lpage>29839</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M002737200</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xe4;rvelin</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Noerenberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Castello</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The New (Dis)order in RNA Regulation</article-title>. <source>Cell Commun Signal</source> <volume>14</volume>, <fpage>9</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-016-0132-3</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kjaergaard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Poulsen</surname>
<given-names>F. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Sequence Correction of Random Coil Chemical Shifts: Correlation between Neighbor Correction Factors and Changes in the Ramachandran Distribution</article-title>. <source>J.&#x20;Biomol. NMR</source> <volume>50</volume> (<issue>2</issue>), <fpage>157</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1007/s10858-011-9508-2</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koensgen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mustea</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Klaman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zafrakas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lichtenegger</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Expression Analysis and RNA Localization of PAI-RBP1 (SERBP1) in Epithelial Ovarian Cancer: Association with Tumor Progression</article-title>. <source>Gynecol. Oncol.</source> <volume>107</volume> (<issue>2</issue>), <fpage>266</fpage>&#x2013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygyno.2007.06.023</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de Araujo</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.-Q.</given-names>
</name>
<name>
<surname>Guardia</surname>
<given-names>G. D. A.</given-names>
</name>
<name>
<surname>Chiou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The RNA-Binding Protein SERBP1 Functions as a Novel Oncogenic Factor in Glioblastoma by Bridging Cancer Metabolism and Epigenetic Regulation</article-title>. <source>Genome Biol.</source> <volume>21</volume>, <fpage>195</fpage>. <pub-id pub-id-type="doi">10.1186/s13059-020-02115-y</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunkle</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Reverse Engineering of Modified Genes by Bayesian Network Analysis Defines Molecular Determinants Critical to the Development of Glioblastoma</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>5</issue>), <fpage>e64140</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0064140</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.-H.</given-names>
</name>
<name>
<surname>J.&#x20;Han</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>E.-J.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J.-E.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>Y.-J.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Understanding Pre-Structured Motifs (PreSMos) in Intrinsically Unfolded Proteins</article-title>. <source>Curr. Protein Pept. Sci.</source> <volume>13</volume> (<issue>1</issue>), <fpage>34</fpage>&#x2013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.2174/138920312799277974</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>W.-Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.-Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Protein Arginine Methylation of SERBP1 by Protein Arginine Methyltransferase 1 Affects Cytoplasmic/nuclear Distribution</article-title>. <source>J.&#x20;Cel. Biochem.</source> <volume>113</volume> (<issue>8</issue>), <fpage>2721</fpage>&#x2013;<lpage>2728</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.24151</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H.-M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.-Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Localization of SERBP1 in Stress Granules and Nucleoli</article-title>. <source>FEBS J.</source> <volume>281</volume> (<issue>1</issue>), <fpage>352</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1111/febs.12606</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemos</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Kobarg</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>CGI-55 Interacts with Nuclear Proteins and Co-Localizes to P80-Coilin Positive-Coiled Bodies in the Nucleus</article-title>. <source>Cell Biochem Biophys.</source> <volume>44</volume> (<issue>3</issue>), <fpage>463</fpage>&#x2013;<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1385/CBB:44:3:463</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43</article-title>. <source>Plos Biol.</source> <volume>14</volume> (<issue>1</issue>), <fpage>e1002338</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1002338</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maharana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pozniakovsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Poser</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>RNA Buffers the Phase Separation Behavior of Prion-Like RNA Binding Proteins</article-title>. <source>Science</source> <volume>360</volume> (<issue>6391</issue>), <fpage>918</fpage>&#x2013;<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1126/science.aar7366</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maris</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dominguez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Allain</surname>
<given-names>F. H.-T.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The RNA Recognition Motif, a Plastic RNA-Binding Platform to Regulate Post-Transcriptional Gene Expression</article-title>. <source>FEBS J.</source> <volume>272</volume> (<issue>9</issue>), <fpage>2118</fpage>&#x2013;<lpage>2131</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2005.04653.x</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marsh</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Forman-Kay</surname>
<given-names>J.&#x20;D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Sequence Determinants of Compaction in Intrinsically Disordered Proteins</article-title>. <source>Biophysical J.</source> <volume>98</volume> (<issue>10</issue>), <fpage>2383</fpage>&#x2013;<lpage>2390</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2010.02.006</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marsh</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Forman-Kay</surname>
<given-names>J.&#x20;D.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Sensitivity of Secondary Structure Propensities to Sequence Differences between &#x3b1;- and &#x3b3;-Synuclein: Implications for Fibrillation</article-title>. <source>Protein Sci.</source> <volume>15</volume> (<issue>12</issue>), <fpage>2795</fpage>&#x2013;<lpage>2804</lpage>. <pub-id pub-id-type="doi">10.1110/ps.062465306</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rance</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>A. G.</given-names>
<suffix>3rd</suffix>
</name>
</person-group> (<year>2004</year>). <article-title>NMR R1&#x3c1; Rotating-Frame Relaxation with Weak Radio Frequency Fields</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>126</volume> (<issue>7</issue>), <fpage>2247</fpage>&#x2013;<lpage>2256</lpage>. <pub-id pub-id-type="doi">10.1021/ja038721w</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sugihara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shibakawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nadano</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The mRNA&#x2010;Binding Protein Serbp1 as an Auxiliary Protein Associated with Mammalian Cytoplasmic Ribosomes</article-title>. <source>Cell Biochem Funct</source> <volume>36</volume> (<issue>6</issue>), <fpage>312</fpage>&#x2013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1002/cbf.3350</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nery</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Passos</surname>
<given-names>D. O.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Kobarg</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Ki-1/57 Interacts with RACK1 and Is a Substrate for the Phosphorylation by Phorbol 12-myristate 13-Acetate-Activated Protein Kinase C</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>279</volume> (<issue>12</issue>), <fpage>11444</fpage>&#x2013;<lpage>11455</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M306672200</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papadopoulos</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Agarwala</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>COBALT: Constraint-Based Alignment Tool for Multiple Protein Sequences</article-title>. <source>Bioinformatics</source> <volume>23</volume> (<issue>9</issue>), <fpage>1073</fpage>&#x2013;<lpage>1079</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btm076</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Mallikarjun</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Swift</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>BioID-Based Proteomic Analysis of the Bid Interactome Identifies Novel Proteins Involved in Cell-Cycle-Dependent Apoptotic Priming</article-title>. <source>Cell Death Dis</source>. <volume>11</volume> (<issue>10</issue>), <fpage>872</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-020-03091-8</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phan</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Kuryavyi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Darnell</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Serganov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Majumdar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ilin</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Structure-Function Studies of FMRP RGG Peptide Recognition of an RNA Duplex-Quadruplex Junction</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>18</volume> (<issue>7</issue>), <fpage>796</fpage>&#x2013;<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2064</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robustelli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Piana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>D. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mechanism of Coupled Folding-Upon-Binding of an Intrinsically Disordered Protein</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>142</volume> (<issue>25</issue>), <fpage>11092</fpage>&#x2013;<lpage>11101</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.0c03217</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabari</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Dall&#x2019;Agnese</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boija</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Coffey</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Shrinivas</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Coactivator Condensation at Super-Enhancers Links Phase Separation and Gene Control</article-title>. <source>Science</source> <volume>361</volume> (<issue>6400</issue>), <fpage>eaar3958</fpage>. <pub-id pub-id-type="doi">10.1126/science.aar3958</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindelin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arganda-Carreras</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Frise</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kaynig</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Longair</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pietzsch</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Fiji: An Open-Source Platform for Biological-Image Analysis</article-title>. <source>Nat. Methods</source> <volume>9</volume> (<issue>7</issue>), <fpage>676</fpage>&#x2013;<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schubert</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Karousis</surname>
<given-names>E. D.</given-names>
</name>
<name>
<surname>Jomaa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scaiola</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Echeverria</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gurzeler</surname>
<given-names>L.-A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>SARS-CoV-2 Nsp1 Binds the Ribosomal mRNA Channel to Inhibit Translation</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>27</volume> (<issue>10</issue>), <fpage>959</fpage>&#x2013;<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1038/s41594-020-0511-8</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuck</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling</article-title>. <source>Biophysical J.</source> <volume>78</volume> (<issue>3</issue>), <fpage>1606</fpage>&#x2013;<lpage>1619</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(00)76713-0</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serce</surname>
<given-names>N. B.</given-names>
</name>
<name>
<surname>Boesl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Klaman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>von Ser&#xe9;nyi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Noetzel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Press</surname>
<given-names>M. F.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Overexpression of SERBP1 (Plasminogen Activator Inhibitor 1 RNA Binding Protein) in Human Breast Cancer Is Correlated with Favourable Prognosis</article-title>. <source>BMC cancer</source> <volume>12</volume>, <fpage>597</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-12-597</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shammas</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Dahal</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wicky</surname>
<given-names>B. I. M.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Insights into Coupled Folding and Binding Mechanisms from Kinetic Studies</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>291</volume> (<issue>13</issue>), <fpage>6689</fpage>&#x2013;<lpage>6695</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R115.692715</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bax</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Protein Backbone and Sidechain Torsion Angles Predicted from NMR Chemical Shifts Using Artificial Neural Networks</article-title>. <source>J.&#x20;Biomol. NMR</source> <volume>56</volume> (<issue>3</issue>), <fpage>227</fpage>&#x2013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1007/s10858-013-9741-y</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skinner</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Fogh</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ragan</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Mureddu</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>Vuister</surname>
<given-names>G. W.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>CcpNmr AnalysisAssign: A Flexible Platform for Integrated NMR Analysis</article-title>. <source>J.&#x20;Biomol. NMR</source> <volume>66</volume> (<issue>2</issue>), <fpage>111</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1007/s10858-016-0060-y</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Calidas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rasoloson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Seydoux</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Spatial Patterning of P Granules by RNA-Induced Phase Separation of the Intrinsically-Disordered Protein MEG-3</article-title>. <source>Elife</source> <volume>5</volume>, <fpage>e21337</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.21337</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Storz</surname>
<given-names>J.&#x20;F.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Causes of Molecular Convergence and Parallelism in Protein Evolution</article-title>. <source>Nat. Rev. Genet.</source> <volume>17</volume> (<issue>4</issue>), <fpage>239</fpage>&#x2013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/nrg.2016.11</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Photoactive G-Quadruplex Ligand Identifies Multiple G-Quadruplex-Related Proteins with Extensive Sequence Tolerance in the Cellular Environment</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>143</volume> (<issue>4</issue>), <fpage>1917</fpage>&#x2013;<lpage>1923</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.0c10792</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugase</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dyson</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>P. E.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Mechanism of Coupled Folding and Binding of an Intrinsically Disordered Protein</article-title>. <source>Nature</source> <volume>447</volume> (<issue>7147</issue>), <fpage>1021</fpage>&#x2013;<lpage>1025</lpage>. <pub-id pub-id-type="doi">10.1038/nature05858</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theile</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Witte</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Blom</surname>
<given-names>A. E. M.</given-names>
</name>
<name>
<surname>Kundrat</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ploegh</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Guimaraes</surname>
<given-names>C. P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Site-Specific N-Terminal Labeling of Proteins Using Sortase-Mediated Reactions</article-title>. <source>Nat. Protoc.</source> <volume>8</volume> (<issue>9</issue>), <fpage>1800</fpage>&#x2013;<lpage>1807</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2013.102</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tompa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fuxreiter</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Fuzzy Complexes: Polymorphism and Structural Disorder in Protein-Protein Interactions</article-title>. <source>Trends Biochem. Sci.</source> <volume>33</volume> (<issue>1</issue>), <fpage>2</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2007.10.003</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Inouye</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Florens</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Washburn</surname>
<given-names>M. P.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>dCas9-Targeted Locus-Specific Protein Isolation Method Identifies Histone Gene Regulators</article-title>. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>115</volume> (<issue>12</issue>), <fpage>E2734</fpage>&#x2013;<lpage>E2741</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1718844115</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uversky</surname>
<given-names>V. N.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Size-Exclusion Chromatography in Structural Analysis of Intrinsically Disordered Proteins</article-title>. <source>Methods Mol. Biol.</source> <volume>896</volume>, <fpage>179</fpage>&#x2013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4614-3704-8_11</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valverde</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Structure and Function of KH Domains</article-title>. <source>FEBS J.</source> <volume>275</volume> (<issue>11</issue>), <fpage>2712</fpage>&#x2013;<lpage>2726</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2008.06411.x</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>MiR-218 Suppresses the Metastasis and EMT of HCC Cells via Targeting SERBP1</article-title>. <source>Acta Biochim. Biophys. Sinica</source> <volume>49</volume> (<issue>5</issue>), <fpage>383</fpage>&#x2013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmx017</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Sodhi</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>McGuffin</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Buxton</surname>
<given-names>B. F.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D. T.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Prediction and Functional Analysis of Native Disorder in Proteins from the Three Kingdoms of Life</article-title>. <source>J.&#x20;Mol. Biol.</source> <volume>337</volume> (<issue>3</issue>), <fpage>635</fpage>&#x2013;<lpage>645</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2004.02.002</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williamson</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Using Chemical Shift Perturbation to Characterise Ligand Binding</article-title>. <source>Prog. Nucl. Magn. Reson. Spectrosc.</source> <volume>73</volume>, <fpage>1</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnmrs.2013.02.001</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ying</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Delaglio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Bax</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Sparse Multidimensional Iterative Lineshape-Enhanced (SMILE) Reconstruction of Both Non-Uniformly Sampled and Conventional NMR Data</article-title>. <source>J.&#x20;Biomol. NMR</source> <volume>68</volume> (<issue>2</issue>), <fpage>101</fpage>&#x2013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1007/s10858-016-0072-7</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Youn</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Dunham</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>J.&#x20;D. R.</given-names>
</name>
<name>
<surname>Bashkurov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G. I.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies</article-title>. <source>Mol. Cel.</source> <volume>69</volume> (<issue>3</issue>), <fpage>517</fpage>&#x2013;<lpage>532</lpage>. <comment>e11</comment>. <pub-id pub-id-type="doi">10.1016/j.molcel.2017.12.020</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>SARS-CoV-2 Hijacks Folate and One-Carbon Metabolism for Viral Replication</article-title>. <source>Nat. Commun.</source> <volume>12</volume> (<issue>1</issue>), <fpage>1676</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-21903-z</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>